The Use of CGMS to Detect Alterations of Blood Glucose in Thalassemic Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03591900

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03591900
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03591900. Randomized; no masking; primary purpose screening. Start 2014-04 (registry gives no type); primary completion 2016-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Use of CGMS to Detect Alterations of Blood Glucose in Thalassemic Patients
Condition
Diabetes
Condition
Prediabetes
Condition
B-Thalassemia
Intervention (Device)
insulin pump/CGMS
Lead sponsor
Ain Shams University (class: other)

Record details

Record id
cardio:ct-nct03591900
Content hash
28ceede15d187ffd040b20faefd5713b197d7920c324b335513d5a602327c4a9